215 related articles for article (PubMed ID: 33183187)
21. Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates.
Blagden N; de Matas M; Gavan PT; York P
Adv Drug Deliv Rev; 2007 Jul; 59(7):617-30. PubMed ID: 17597252
[TBL] [Abstract][Full Text] [Related]
22. Pharmaceutical cocrystals: the coming wave of new drug substances.
Brittain HG
J Pharm Sci; 2013 Feb; 102(2):311-7. PubMed ID: 23192888
[TBL] [Abstract][Full Text] [Related]
23. Co-Crystallization: A Novel Technique to Improvise the Pharmaceutical Characteristics of API's.
Kumar A; Kumar M
Curr Drug Targets; 2023; 24(11):870-888. PubMed ID: 37496134
[TBL] [Abstract][Full Text] [Related]
24. Nano-sized Solid Dispersions for Improving the Bioavailability of Poorly Water-soluble Drugs.
Tran PHL; Tran TTD
Curr Pharm Des; 2020; 26(38):4917-4924. PubMed ID: 32611298
[TBL] [Abstract][Full Text] [Related]
25. Research Progress of Plant Active Ingredients in Pharmaceutical Cocrystal.
Wang Z; Shang H; Gao L; Qiao N
Curr Drug Deliv; 2023; 20(10):1405-1424. PubMed ID: 35993478
[TBL] [Abstract][Full Text] [Related]
26. Engineering and manufacturing of pharmaceutical co-crystals: a review of solvent-free manufacturing technologies.
Ross SA; Lamprou DA; Douroumis D
Chem Commun (Camb); 2016 Jul; 52(57):8772-86. PubMed ID: 27302311
[TBL] [Abstract][Full Text] [Related]
27. Pharmaceutical cocrystals: walking the talk.
Bolla G; Nangia A
Chem Commun (Camb); 2016 Jun; 52(54):8342-60. PubMed ID: 27278109
[TBL] [Abstract][Full Text] [Related]
28. Supercritical fluid (SCF)-assisted fabrication of carrier-free drugs: An eco-friendly welcome to active pharmaceutical ingredients (APIs).
Kankala RK; Xu PY; Chen BQ; Wang SB; Chen AZ
Adv Drug Deliv Rev; 2021 Sep; 176():113846. PubMed ID: 34197896
[TBL] [Abstract][Full Text] [Related]
29. Ternary solid dispersions: classification and formulation considerations.
Borde S; Paul SK; Chauhan H
Drug Dev Ind Pharm; 2021 Jul; 47(7):1011-1028. PubMed ID: 33818224
[TBL] [Abstract][Full Text] [Related]
30. Bioavailability Enhancement Techniques for Poorly Aqueous Soluble Drugs and Therapeutics.
Bhalani DV; Nutan B; Kumar A; Singh Chandel AK
Biomedicines; 2022 Aug; 10(9):. PubMed ID: 36140156
[TBL] [Abstract][Full Text] [Related]
31. Challenges in Translational Development of Pharmaceutical Cocrystals.
Kale DP; Zode SS; Bansal AK
J Pharm Sci; 2017 Feb; 106(2):457-470. PubMed ID: 27914793
[TBL] [Abstract][Full Text] [Related]
32. Raman and Terahertz Spectroscopic Characterization of Solid-state Cocrystal Formation within Specific Active Pharmaceutical Ingredients.
Du Y; Xue J; Hong Z
Curr Pharm Des; 2020; 26(38):4829-4846. PubMed ID: 32445442
[TBL] [Abstract][Full Text] [Related]
33. Optimizing Drug Development: Harnessing the Sustainability of Pharmaceutical Cocrystals.
Aitipamula S; Bolla G
Mol Pharm; 2024 Jul; 21(7):3121-3143. PubMed ID: 38814314
[TBL] [Abstract][Full Text] [Related]
34. Advancement in Solubilization Approaches: A Step towards Bioavailability Enhancement of Poorly Soluble Drugs.
Kumari L; Choudhari Y; Patel P; Gupta GD; Singh D; Rosenholm JM; Bansal KK; Kurmi BD
Life (Basel); 2023 Apr; 13(5):. PubMed ID: 37240744
[TBL] [Abstract][Full Text] [Related]
35. Obtaining Cocrystals by Reaction Crystallization Method: Pharmaceutical Applications.
Biscaia IFB; Gomes SN; Bernardi LS; Oliveira PR
Pharmaceutics; 2021 Jun; 13(6):. PubMed ID: 34204318
[TBL] [Abstract][Full Text] [Related]
36. Solid-state and particle size control of pharmaceutical cocrystals using atomization-based techniques.
O'Sullivan A; Long B; Verma V; Ryan KM; Padrela L
Int J Pharm; 2022 Jun; 621():121798. PubMed ID: 35525471
[TBL] [Abstract][Full Text] [Related]
37. Drug carrier systems for solubility enhancement of BCS class II drugs: a critical review.
Kumar S; Bhargava D; Thakkar A; Arora S
Crit Rev Ther Drug Carrier Syst; 2013; 30(3):217-56. PubMed ID: 23614647
[TBL] [Abstract][Full Text] [Related]
38. A Comprehensive Insight on Pharmaceutical Co-crystals for Improvement of Aqueous Solubility.
Malik J; Khatkar A; Nanda A
Curr Drug Targets; 2023; 24(2):157-170. PubMed ID: 36380409
[TBL] [Abstract][Full Text] [Related]
39. Application of Cocrystallization Approach in Drug Development: Recent Patents Review.
Shah K; Parmar VK
Recent Pat Nanotechnol; 2018; 12(2):143-154. PubMed ID: 29473529
[TBL] [Abstract][Full Text] [Related]
40. Nanotechnology versus other techniques in improving drug dissolution.
Kwok PC; Chan HK
Curr Pharm Des; 2014; 20(3):474-82. PubMed ID: 23651399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
